BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21865166)

  • 1. Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor.
    Zheng H; Qian J; Baker DP; Fuchs SY
    J Biol Chem; 2011 Oct; 286(41):35733-35741. PubMed ID: 21865166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2.
    Zheng H; Qian J; Varghese B; Baker DP; Fuchs S
    Mol Cell Biol; 2011 Feb; 31(4):710-20. PubMed ID: 21173164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor.
    Bhattacharya S; Qian J; Tzimas C; Baker DP; Koumenis C; Diehl JA; Fuchs SY
    J Biol Chem; 2011 Jun; 286(25):22069-76. PubMed ID: 21540188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
    Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
    Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TYK2 activity promotes ligand-induced IFNAR1 proteolysis.
    Marijanovic Z; Ragimbeau J; Kumar KG; Fuchs SY; Pellegrini S
    Biochem J; 2006 Jul; 397(1):31-8. PubMed ID: 16551269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
    Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
    Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor.
    Bhattacharya S; HuangFu WC; Liu J; Veeranki S; Baker DP; Koumenis C; Diehl JA; Fuchs SY
    J Biol Chem; 2010 Jan; 285(4):2318-25. PubMed ID: 19948722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor.
    Kumar KG; Krolewski JJ; Fuchs SY
    J Biol Chem; 2004 Nov; 279(45):46614-20. PubMed ID: 15337770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis.
    Zheng H; Qian J; Carbone CJ; Leu NA; Baker DP; Fuchs SY
    Blood; 2011 Oct; 118(14):4003-6. PubMed ID: 21832278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
    Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.
    Kumar KG; Varghese B; Banerjee A; Baker DP; Constantinescu SN; Pellegrini S; Fuchs SY
    J Biol Chem; 2008 Jul; 283(27):18566-72. PubMed ID: 18474601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.
    Piganis RA; De Weerd NA; Gould JA; Schindler CW; Mansell A; Nicholson SE; Hertzog PJ
    J Biol Chem; 2011 Sep; 286(39):33811-8. PubMed ID: 21757742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.
    Gauzzi MC; Barbieri G; Richter MF; Uzé G; Ling L; Fellous M; Pellegrini S
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11839-44. PubMed ID: 9342324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol.
    Su L; David M
    J Biol Chem; 2000 Apr; 275(17):12661-6. PubMed ID: 10777558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
    Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
    J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
    Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
    Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.
    Colamonici O; Yan H; Domanski P; Handa R; Smalley D; Mullersman J; Witte M; Krishnan K; Krolewski J
    Mol Cell Biol; 1994 Dec; 14(12):8133-42. PubMed ID: 7526154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-independent pathway that controls stability of interferon alpha receptor.
    Liu J; Plotnikov A; Banerjee A; Suresh Kumar KG; Ragimbeau J; Marijanovic Z; Baker DP; Pellegrini S; Fuchs SY
    Biochem Biophys Res Commun; 2008 Mar; 367(2):388-93. PubMed ID: 18166147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein.
    Ahmad S; Alsayed YM; Druker BJ; Platanias LC
    J Biol Chem; 1997 Nov; 272(48):29991-4. PubMed ID: 9374471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.